Jarrow Formulas QH-Absorb Ubiquinol 200mg
Best OverallForm: Ubiquinol (active CoQ10)
~$0.60–0.80/softgel
Quick Comparison
| Product | Key Specs | Price Range |
|---|---|---|
| |
| ~$0.60–0.80/softgel |
| |
| ~$1.50–2.00/day (28-day supply) |
| |
| ~$1.20–1.60/day |
| |
| ~$0.55–0.75/softgel |
Contains affiliate links — we may earn a small commission at no extra cost to you.
Best CoQ10 for Egg Quality 2026: Top Ubiquinol Picks Ranked
If you’re researching CoQ10 for egg quality, you’ve likely encountered the recommendation from fertility specialists, reproductive endocrinologists, and fertility communities: start ubiquinol 2–3 months before IVF retrieval or a planned conception attempt. The science behind this recommendation has grown substantially over the past decade, driven by a clearer mechanistic understanding of mitochondrial function in oocyte maturation and a growing body of randomized controlled trials in women with diminished ovarian reserve.
This guide covers what the research actually shows, where the evidence gaps are, and which CoQ10 ubiquinol supplements are worth considering based on ingredient quality, dose, and value. Every product is evaluated using our G6 composite scoring methodology: Evidence Quality (30%), Ingredient Transparency (25%), Value (20%), Real-World Performance (15%), and Third-Party Verification (10%).
For a broader overview of fertility supplement evidence, see our Fertility Supplements That Actually Work guide, which covers CoQ10 alongside myo-inositol, methylfolate, and vitamin D.
Why CoQ10 Matters for Oocyte Quality
Oocyte maturation is one of the most energy-demanding biological processes in the human body. A primary oocyte must complete the final stages of meiotic maturation — correctly segregating chromosomes and building the machinery for fertilization — while relying almost entirely on its own mitochondrial ATP production. There are no blood vessels supplying energy directly to a maturing oocyte; it depends on its internal mitochondrial function and the oxygen-rich follicular fluid surrounding it.
This is where CoQ10 becomes mechanistically relevant:
Mitochondrial electron transport: CoQ10 (as ubiquinol, its active antioxidant form) is an essential electron carrier in the mitochondrial electron transport chain (Complexes I–III). Without adequate CoQ10, electron transfer slows and ATP production declines — directly impairing the energy available for chromosomal segregation during meiosis.
Follicular fluid antioxidant protection: Reactive oxygen species (ROS) are generated during follicular growth. Ubiquinol is a fat-soluble antioxidant in cell membranes; elevated follicular fluid CoQ10 reduces oxidative damage to the oocyte during maturation. Research by Giannubilo SR et al. (2018, Antioxidants, PMID: 30322142) found that oral CoQ10 supplementation significantly increased follicular fluid CoQ10 concentration and improved oxidative status in follicles, with strongest effects in women over 35.
Age-related decline: Ben-Meir A et al. (2015, Aging Cell, PMID: 26111777) demonstrated in a mouse model that reproductive aging is associated with reduced expression of CoQ10-synthesizing enzymes (Pdss2, Coq6) in oocytes, resulting in mitochondrial dysfunction, spindle abnormalities, and elevated aneuploidy. CoQ10 supplementation in older mice restored ovarian reserve, ovulation rates, and litter sizes. While mouse models don’t directly prove human efficacy, this established the mechanistic framework that human RCTs have since tested.
What the Clinical Evidence Shows
Three systematic reviews and meta-analyses now synthesize the human trial evidence:
Lin G et al., 2024 (Ann Med, PMID: 39129455) — The largest meta-analysis to date. Six RCTs, 1,529 participants with diminished ovarian reserve (DOR) undergoing IVF/ICSI. CoQ10 pretreatment was associated with:
- Clinical pregnancy rate: OR = 1.84 (95% CI: 1.33–2.53)
- Number of oocytes retrieved: MD = +1.30
- Cycle cancellation: OR = 0.60 (40% relative reduction)
- Miscarriage rate: OR = 0.38
Florou P et al., 2020 (J Assist Reprod Genet, PMID: 32767206) — Five RCTs, 449 infertile women undergoing ART. Clinical pregnancy rate significantly higher with CoQ10 vs. control: 28.8% vs. 14.1%, OR = 2.44 (95% CI: 1.30–4.59). Subgroup analysis confirmed significance in both poor ovarian response and PCOS populations. No significant effect on live birth rates was demonstrated in this smaller dataset.
Xu Y, Nisenblat V et al., 2018 (Reprod Biol Endocrinol, PMID: 29587861) — RCT of 169 young women with poor ovarian response (POSEIDON criteria, age <35). 60-day CoQ10 pretreatment before IVF-ICSI: fertilization rate 67.49% vs. controls, cancelled embryo transfers reduced from 22.89% to 8.33% (p=0.04), more cryopreserved embryos available (18.42% vs. 4.3%, p=0.012).
Important caveat: A 2021 review by Rodríguez-Varela C & Labarta E (Int J Mol Sci, PMID: 34502447) concluded that while biological rationale is sound, “the available data do not clearly prove its ability to improve human oocyte quality” — especially outside of DOR/poor responder populations — and called for more rigorous trials. The evidence is strongest in women with diminished ovarian reserve undergoing IVF, and meaningfully less established for women with normal ovarian reserve.
Top CoQ10 Supplements for Egg Quality Reviewed
1. Jarrow Formulas QH-Absorb Ubiquinol 200mg — Best Overall
Jarrow QH-Absorb is the most commonly recommended CoQ10 supplement in fertility communities for a reason: it delivers 200mg of ubiquinol per softgel in a clean, single-ingredient formula with no unnecessary additives. At the standard fertility protocol dose of 2–3 softgels daily (400–600mg), this product provides cost-effective access to the active form at clinically relevant doses.
The QH-Absorb formulation uses a phospholipid-enhanced absorption matrix. Ubiquinol is the reduced (electron-rich) form of CoQ10 — the form that directly functions as an antioxidant in cell membranes without requiring enzymatic conversion from ubiquinone. This matters because the conversion of ubiquinone to ubiquinol declines with age, making ubiquinol supplementation particularly relevant for women over 35 or those with diminished ovarian reserve.
Key specs:
- Form: Ubiquinol (active, reduced CoQ10)
- Dose: 200mg/softgel (use 2–3 for fertility protocol)
- Certification: cGMP, Non-GMO
- Formula: Single ingredient — no fillers, no unnecessary excipients
- Container: 60 softgels (30-day supply at 2/day, 20-day at 3/day)
Who it’s for: Women using CoQ10 as part of a pre-conception or IVF protocol who want a well-established, cost-effective ubiquinol option at fertility-grade doses. Particularly relevant for women over 35, those with diminished ovarian reserve (AMH <1 ng/mL), or poor ovarian response.
Pros:
- Clean single-ingredient formula — transparent dosing, no proprietary blend concerns
- 200mg/softgel makes dose titration to 400–600mg straightforward
- Long established track record with consistent verified-purchaser reports from fertility communities
- Competitive cost-per-dose at fertility protocol quantities
Cons:
- No third-party certification beyond cGMP (no NSF, USP, or Informed Sport)
- Plain packaging — no fertility-specific branding or consumer education resources
Price: ~$0.60–0.80/softgel; ~$1.20–2.40/day at fertility protocol doses
G6 Composite Score: 8.9/10
| Criterion | Weight | Score | Weighted |
|---|---|---|---|
| Evidence Quality | 30% | 9.0 | 2.70 |
| Ingredient Transparency | 25% | 9.5 | 2.38 |
| Value | 20% | 9.0 | 1.80 |
| Real-World Performance | 15% | 8.5 | 1.28 |
| Third-Party Verification | 10% | 7.0 | 0.70 |
| Composite | 8.86 → 8.9 |
Evidence Quality 9.0: Ubiquinol form with robust fertility literature. Ingredient Transparency 9.5: Single-ingredient, fully disclosed dosing. Value 9.0: Best cost-per-day at protocol dose among ubiquinol options. Third-Party Verification 7.0: cGMP certified but no NSF/USP.
2. Ovaterra OvoEnergen CoQ10 for Women — Best Fertility-Specific
Ovaterra’s OvoEnergen is designed specifically for women pursuing IVF or natural conception, and it uses Kaneka QH — the same licensed ubiquinol ingredient used in several clinical fertility studies. Each 100mg softgel is formulated with VESIsorb® absorption technology, a colloidal delivery system that improves bioavailability of lipid-soluble compounds like ubiquinol in the gastrointestinal tract.
The fertility-specific positioning means the product is formulated, labeled, and marketed with dosing guidance for pre-conception protocols (84 softgels = 28-day supply at 3 softgels/day = 300mg/day, with option to increase). The Kaneka QH ingredient provides traceability to clinical-grade ubiquinol.
Key specs:
- Form: Ubiquinol (Kaneka QH licensed ingredient)
- Dose: 100mg/softgel; 3/day for 300mg protocol
- Technology: VESIsorb® enhanced absorption delivery
- Design intent: Pre-conception and IVF preparation
- Container: 84 softgels (28-day supply at 3/day)
Who it’s for: Women who want a fertility-specific CoQ10 product using a licensed, traceable ubiquinol ingredient and enhanced absorption technology; women who appreciate purpose-built fertility supplement design rather than adapting a general CoQ10 product.
Pros:
- Kaneka QH: the most-studied commercial ubiquinol ingredient — direct traceability to clinical trial material
- VESIsorb® technology provides enhanced aqueous dispersibility, potentially increasing absorption in individuals with variable fat absorption
- Purpose-built for fertility use cases with consumer-friendly dosing guidance
- Conveniently sized softgels for fertility protocol compliance
Cons:
- Higher cost per serving than generic ubiquinol options
- 300mg/day at standard protocol may fall below the 400–600mg/day range used in the largest RCTs — would require 4–6 softgels/day to reach the higher clinical doses
- No independent NSF or USP certification listed
Price: ~$1.50–2.00/day at standard 3/day protocol
G6 Composite Score: 8.4/10
| Criterion | Weight | Score | Weighted |
|---|---|---|---|
| Evidence Quality | 30% | 9.0 | 2.70 |
| Ingredient Transparency | 25% | 8.5 | 2.13 |
| Value | 20% | 7.0 | 1.40 |
| Real-World Performance | 15% | 8.5 | 1.28 |
| Third-Party Verification | 10% | 8.0 | 0.80 |
| Composite | 8.31 → 8.4 |
Evidence Quality 9.0: Kaneka QH directly traceable to clinical trial ubiquinol material. Ingredient Transparency 8.5: Fully disclosed, but VESIsorb carrier system adds complexity. Value 7.0: Highest per-day cost of reviewed products. Third-Party Verification 8.0: Kaneka QH licensed ingredient provides meaningful quality assurance.
3. Life Extension Super Ubiquinol CoQ10 200mg — Best Mitochondrial Stack
Life Extension’s Super Ubiquinol formula pairs 200mg of ubiquinol with shilajit — a mineral-rich resin compound with growing evidence for enhancing mitochondrial CoQ10 utilization via its primary active component, fulvic acid. The combination is designed to synergistically support mitochondrial energy production: ubiquinol provides the electron carrier, while shilajit fulvic acid is proposed to enhance CoQ10 integration into mitochondrial membranes and support complex assembly.
This is a meaningful distinction for women who want comprehensive mitochondrial support rather than CoQ10 alone. Life Extension has a long-established reputation for evidence-based supplement formulation, and this product reflects their approach to multi-mechanism mitochondrial support.
Key specs:
- Form: Ubiquinol 200mg + shilajit extract
- Dose: 200mg ubiquinol/softgel; 1 softgel = standard dose; 2 for fertility protocol
- Certification: Non-GMO, Gluten-Free, cGMP
- Container: 30 softgels at 200mg
Who it’s for: Women who want mitochondrial support beyond CoQ10 alone; those who are pursuing a comprehensive mitochondrial optimization approach to fertility support alongside CoQ10; women who respond well to Life Extension products and trust the brand’s formulation philosophy.
Pros:
- Shilajit fulvic acid adds a mechanistically complementary mitochondrial support component
- Life Extension’s quality control and formulation track record
- 200mg per softgel provides adequate dose flexibility
- Non-GMO and gluten-free
Cons:
- The addition of shilajit, while potentially beneficial, means this is no longer a simple single-ingredient CoQ10 product — less studied specifically in fertility RCTs
- Shilajit sourcing quality varies enormously across brands; this product does not specify heavy metal testing certification
- Higher cost per serving than Jarrow at equivalent ubiquinol dose
- No NSF or USP certification
Price: ~$1.20–1.60/day at 2 softgels/day fertility protocol
G6 Composite Score: 8.0/10
| Criterion | Weight | Score | Weighted |
|---|---|---|---|
| Evidence Quality | 30% | 8.5 | 2.55 |
| Ingredient Transparency | 25% | 8.0 | 2.00 |
| Value | 20% | 7.5 | 1.50 |
| Real-World Performance | 15% | 8.5 | 1.28 |
| Third-Party Verification | 10% | 7.0 | 0.70 |
| Composite | 8.03 → 8.0 |
Evidence Quality 8.5: Strong for CoQ10 component; shilajit adds mechanistic support with less fertility-specific evidence. Ingredient Transparency 8.0: Both ingredients disclosed, but shilajit quality and sourcing are not independently verified. Value 7.5: Moderate cost premium for the combination formula.
4. Qunol Mega Ubiquinol 200mg — Best Absorption/Value
Qunol’s Mega Ubiquinol 200mg uses a solubilized ubiquinol formulation — a water-and-fat-soluble delivery system designed to address the low oral bioavailability of standard lipid-phase CoQ10 preparations. The solubilization technology may improve absorption consistency, particularly in individuals who have variable fat intake at mealtimes (standard CoQ10 absorption is fat-dependent).
At 200mg per softgel with competitive pricing, Qunol provides a solid ubiquinol option for women who want the active form at an accessible price point without specialty fertility-specific branding.
Key specs:
- Form: Ubiquinol (water and fat-soluble solubilized formulation)
- Dose: 200mg/softgel
- Certification: cGMP
- Container: 60 softgels
Who it’s for: Women seeking a cost-effective ubiquinol supplement at standard fertility protocol doses; women who have variable meal composition and may benefit from a solubilized formulation for absorption consistency.
Pros:
- Solubilized ubiquinol may improve absorption consistency regardless of meal fat content
- Competitive pricing at fertility protocol doses (2 softgels/day = 400mg)
- Widely available, easy to find and reorder
- 200mg/softgel dose is practical for standard fertility protocol quantities
Cons:
- No NSF, USP, or Informed Sport certification
- Solubilization excipients not fully detailed on label
- Less fertility-specific community track record compared to Jarrow QH-Absorb
- No licensed ubiquinol ingredient (Kaneka QH) designation
Price: ~$0.55–0.75/softgel; ~$1.10–1.50/day at 2 softgels/day
G6 Composite Score: 7.8/10
| Criterion | Weight | Score | Weighted |
|---|---|---|---|
| Evidence Quality | 30% | 8.0 | 2.40 |
| Ingredient Transparency | 25% | 8.0 | 2.00 |
| Value | 20% | 8.5 | 1.70 |
| Real-World Performance | 15% | 7.5 | 1.13 |
| Third-Party Verification | 10% | 6.5 | 0.65 |
| Composite | 7.88 → 7.8 |
Evidence Quality 8.0: Standard ubiquinol evidence applies; no fertility-specific trials for this exact formulation. Ingredient Transparency 8.0: Ubiquinol dose clearly disclosed, solubilization system not fully detailed. Third-Party Verification 6.5: cGMP only; no independent analytical certification.
Head-to-Head Comparison
| Feature | Jarrow QH-Absorb 200mg | Ovaterra OvoEnergen | Life Extension Ubiquinol 200mg | Qunol Mega Ubiquinol 200mg |
|---|---|---|---|---|
| Form | Ubiquinol | Ubiquinol (Kaneka QH) | Ubiquinol + Shilajit | Ubiquinol (solubilized) |
| Dose/Softgel | 200mg | 100mg | 200mg | 200mg |
| Cost/Day (400mg protocol) | ~$1.20–1.60 | ~$2.00–2.67 | ~$1.20–1.60 | ~$1.10–1.50 |
| Licensed Ingredient | No | Yes (Kaneka QH) | No | No |
| Third-Party Cert | cGMP | Kaneka QH | cGMP | cGMP |
| Single Ingredient | Yes | Yes | No (+ shilajit) | Yes |
| Best For | Overall value & dose | Fertility-specific, traceable ingredient | Mitochondrial stack | Value/absorption consistency |
| G6 Score | 8.9 | 8.4 | 8.0 | 7.8 |
Who Should Consider CoQ10 for Egg Quality
Women over 35 with declining ovarian reserve: This is the population with the most RCT evidence. The majority of clinical trials used women with diminished ovarian reserve (DOR, typically defined as AMH <1 ng/mL or AFC <7) undergoing IVF. If you’re 35+ and have been told your ovarian reserve is lower than expected for age, the evidence supporting CoQ10 supplementation is the strongest here.
Women preparing for IVF egg retrieval: The 60–90 day protocol aligns with the oocyte maturation window. Starting CoQ10 supplementation 2–3 months before your scheduled retrieval date gives the maximum time for CoQ10 to accumulate in follicular fluid and oocyte mitochondria during the critical maturation period.
Women with poor ovarian response in prior IVF cycles: Research by Xu Y et al. (2018, PMID: 29587861) specifically demonstrated benefit in young women (age <35) who were poor ovarian responders — a POSEIDON classification defined by unexpectedly low yield despite adequate stimulation. This is an important subgroup because it shows the mechanism is not purely age-driven but relates to oocyte mitochondrial efficiency.
Women pursuing natural conception over 35: The evidence from IVF studies does not directly translate to natural conception outcomes, but the biological mechanism (mitochondrial ATP support during oocyte maturation) operates identically in natural cycles. Many reproductive endocrinologists recommend CoQ10 for women over 35 pursuing natural conception, though no large natural conception RCT exists to date.
Women with PCOS: The Florou meta-analysis (2020, PMID: 32767206) confirmed efficacy in PCOS subgroup analysis — CoQ10 may provide benefit in the context of the metabolic and oxidative stress associated with PCOS, separate from the pure DOR mechanism.
Frequently Asked Questions
Does CoQ10 actually improve egg quality?
For women with diminished ovarian reserve (DOR) or poor ovarian response, the evidence is reasonably strong. A 2024 meta-analysis (Lin G et al., Ann Med, PMID: 39129455) of six RCTs involving 1,529 women with DOR found CoQ10 pretreatment before IVF/ICSI significantly improved clinical pregnancy rates (OR=1.84), number of oocytes retrieved, and optimal embryo counts. Evidence in young women with normal ovarian reserve pursuing natural conception is less established by clinical trials.
What is the best dose of CoQ10 for egg quality?
Clinical fertility protocols typically use 400–600mg/day of ubiquinol starting 60–90 days before egg retrieval or planned conception. The 90-day lead time aligns with the oocyte maturation window from primordial follicle to ovulation. Lower doses (200mg/day) have also shown follicular fluid benefit (Giannubilo et al., 2018, PMID: 30322142), but higher doses are used in women with DOR or over 35.
What is the difference between ubiquinol and ubiquinone for fertility?
Ubiquinol is the reduced, active antioxidant form of CoQ10; ubiquinone is the oxidized precursor that must be converted to ubiquinol in the body. For fertility applications, ubiquinol is generally preferred because it does not require enzymatic conversion — important for older women or those whose mitochondrial CoQ10 production may be impaired with age. Most fertility-specific CoQ10 supplements now use Kaneka QH, a licensed ubiquinol ingredient traceable to clinical trial material.
When should I start taking CoQ10 for egg quality?
Start 2–3 months (60–90 days) before your target egg retrieval date or planned conception attempt. This aligns with the biological timeline of oocyte maturation — primary oocytes take approximately 90 days to complete final maturation stages before ovulation. Starting earlier allows CoQ10 to accumulate in follicular fluid and oocyte mitochondria during the critical energy-intensive maturation period.
Is CoQ10 safe to take while trying to conceive?
CoQ10 has a well-established safety profile at doses up to 600mg/day. Adverse effects are mild and primarily gastrointestinal at higher doses. The standard practice in IVF protocols is to discontinue CoQ10 after egg retrieval and resume only with physician guidance after a positive pregnancy test. Women on warfarin or antihypertensive medications should consult their physician before starting, as CoQ10 may interact with both drug classes.
Final Verdict
For women seeking evidence-based CoQ10 supplementation for egg quality, Jarrow Formulas QH-Absorb Ubiquinol 200mg is the top-rated option based on its combination of clinical-grade ubiquinol form, transparent single-ingredient formula, practical 200mg/softgel dosing for fertility protocol quantities, and competitive cost per day. It scores 8.9/10 on our G6 composite.
Women who specifically want a fertility-purpose-built product with a licensed, traceable ubiquinol ingredient should consider Ovaterra OvoEnergen (8.4/10), which uses Kaneka QH and VESIsorb technology for enhanced absorption.
Women who want mitochondrial support beyond CoQ10 alone can consider Life Extension Super Ubiquinol (8.0/10), which adds shilajit for complementary mitochondrial energy support.
For women prioritizing value and absorption consistency, Qunol Mega Ubiquinol (7.8/10) provides a competitively priced solubilized ubiquinol option.
A critical note on evidence limitations: The clinical evidence is strongest for women with diminished ovarian reserve undergoing IVF/ICSI. If you have normal ovarian reserve and are pursuing natural conception, CoQ10 supplementation has strong mechanistic rationale but less direct RCT support — discuss the evidence and your specific situation with your reproductive endocrinologist or OB-GYN before starting a supplementation protocol.
Frequently Asked Questions
- For women with diminished ovarian reserve (DOR) or poor ovarian response, the evidence is reasonably strong. A 2024 meta-analysis (Lin G et al., Ann Med, PMID 39129455) of six RCTs involving 1,529 women with DOR found CoQ10 pretreatment before IVF/ICSI significantly improved clinical pregnancy rates (OR=1.84), number of oocytes retrieved, and optimal embryo counts. Evidence in young women with normal ovarian reserve pursuing natural conception is less established by clinical trials.
- Clinical fertility protocols typically use 400–600mg/day of ubiquinol starting 60–90 days before egg retrieval or planned conception. The 90-day lead time aligns with the oocyte maturation window from primordial follicle to ovulation. Lower doses (200mg/day) have also shown follicular fluid benefit (Giannubilo et al., 2018, PMID 30322142), but higher doses are used in women with DOR or over 35.
- Ubiquinol is the reduced, active antioxidant form of CoQ10; ubiquinone is the oxidized precursor that must be converted to ubiquinol in the body. For fertility applications, ubiquinol is generally preferred because it does not require enzymatic conversion — important for older women or those whose mitochondrial CoQ10 production may be impaired with age. Most fertility-specific CoQ10 supplements now use Kaneka QH (a licensed ubiquinol ingredient).
- Start 2–3 months (60–90 days) before your target egg retrieval date or planned conception attempt. This aligns with the biological timeline of oocyte maturation — primary oocytes take approximately 90 days to complete final maturation stages before ovulation. Starting earlier allows CoQ10 to accumulate in follicular fluid and oocyte mitochondria during the critical energy-intensive maturation period.
- CoQ10 has a well-established safety profile at doses up to 600mg/day. Adverse effects are mild and primarily gastrointestinal at higher doses. The standard practice in IVF protocols is to discontinue CoQ10 after egg retrieval and resume only with physician guidance after a positive pregnancy test. Women on warfarin or antihypertensive medications should consult their physician before starting, as CoQ10 may interact with both drug classes.